Skip to main content

Research news from the Virtual EASD Annual Meeting 2020

Research news from the Virtual EASD Annual Meeting 2020

09-25-2020 | EASD 2020 | Conference coverage | Article

DAPA-CKD trial: Renal benefits of SGLT2 inhibition in people with and without diabetes

DAPA-CKD lead investigator Hiddo Heerspink discusses the positive outcomes of dapagliflozin treatment in people with kidney disease both with and without type 2 diabetes (8:13).

09-25-2020 | EASD 2020 | Conference coverage | News

Ethnicity, obesity linked to risk for early-onset type 2 diabetes

The development of type 2 diabetes at a young age disproportionately affects people of South Asian and African–Caribbean ethnicity, and obesity is associated with early-onset diabetes in all ethnic groups, indicates research presented at the virtual 56th EASD Annual Meeting.

09-26-2020 | EASD 2020 | Conference coverage | News

Cardioprotective measures neglected in young-onset type 2 diabetes

People with type 2 diabetes, especially young people, do not receive treatment for hypertension and dyslipidemia in a timely manner, even when they have high cardiovascular risk, study results show.

09-29-2020 | EASD 2020 | Conference coverage | Article

EMPEROR-Reduced: Time for a change in the HF guidelines?

10-07-2020 | EASD 2020 | Conference coverage | Article

EASD 2020: Editorial Board conference highlights